Ouch to the remaining shorts as it includes the UK ... LMAO
Melbourne, Australia; 23 February 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) announced today it had received confirmation that the VIRALEZE™ antiviral nasal spray has been successfully registered for sale in Europe, including in the UK.
Ann: VIRALEZE antiviral nasal spray registered in Europe, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.38M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.0¢ | 9.8¢ | $10.97K | 110.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 954 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 48907 | 4 |
View Market Depth
| Last trade - 13.20pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 10.0¢ | 19731 | ||
| Last updated 12.41pm 11/06/2024 ? | |||||
| SPL (ASX) Chart |